Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve Stenosis | 6 | 2025 | 156 | 1.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2024 | 192 | 1.360 |
Why?
|
| Transcatheter Aortic Valve Replacement | 4 | 2025 | 80 | 1.080 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2023 | 81 | 0.980 |
Why?
|
| Balloon Valvuloplasty | 3 | 2020 | 9 | 0.830 |
Why?
|
| Cardiac Catheterization | 5 | 2024 | 307 | 0.810 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2024 | 179 | 0.730 |
Why?
|
| Drug-Eluting Stents | 4 | 2016 | 24 | 0.730 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2010 | 66 | 0.650 |
Why?
|
| Coronary Artery Disease | 4 | 2025 | 387 | 0.610 |
Why?
|
| Coronary Vessels | 3 | 2025 | 178 | 0.540 |
Why?
|
| Angioplasty | 2 | 2014 | 68 | 0.490 |
Why?
|
| Stents | 2 | 2008 | 433 | 0.410 |
Why?
|
| Atrial Flutter | 1 | 2014 | 45 | 0.410 |
Why?
|
| Septal Occluder Device | 1 | 2014 | 52 | 0.400 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 57 | 0.400 |
Why?
|
| Atrial Appendage | 1 | 2014 | 45 | 0.390 |
Why?
|
| Coronary Angiography | 4 | 2025 | 237 | 0.390 |
Why?
|
| Aortic Diseases | 1 | 2013 | 88 | 0.380 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2013 | 107 | 0.380 |
Why?
|
| Heart Valve Prosthesis | 4 | 2024 | 97 | 0.370 |
Why?
|
| Heart Atria | 1 | 2014 | 255 | 0.370 |
Why?
|
| Treatment Outcome | 16 | 2025 | 9711 | 0.350 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2022 | 133 | 0.340 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2023 | 508 | 0.330 |
Why?
|
| Prosthesis Failure | 2 | 2024 | 117 | 0.330 |
Why?
|
| Coronary Restenosis | 1 | 2010 | 13 | 0.320 |
Why?
|
| Prosthesis Design | 4 | 2024 | 308 | 0.310 |
Why?
|
| Paclitaxel | 2 | 2016 | 483 | 0.300 |
Why?
|
| Sirolimus | 1 | 2010 | 182 | 0.280 |
Why?
|
| Coronary Aneurysm | 1 | 2008 | 15 | 0.280 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 194 | 0.280 |
Why?
|
| Mitral Valve | 5 | 2024 | 229 | 0.280 |
Why?
|
| Embolism | 1 | 2006 | 32 | 0.230 |
Why?
|
| Chest Pain | 1 | 2006 | 44 | 0.230 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2025 | 4 | 0.220 |
Why?
|
| Computed Tomography Angiography | 2 | 2025 | 188 | 0.220 |
Why?
|
| Multidetector Computed Tomography | 1 | 2025 | 57 | 0.210 |
Why?
|
| Bioprosthesis | 1 | 2024 | 42 | 0.210 |
Why?
|
| Femoral Artery | 2 | 2017 | 96 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2022 | 11 | 0.190 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2022 | 11 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 2013 | 0.180 |
Why?
|
| Male | 16 | 2025 | 47075 | 0.180 |
Why?
|
| Aged | 12 | 2025 | 21758 | 0.180 |
Why?
|
| Aortic Valve | 2 | 2022 | 258 | 0.180 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2016 | 272 | 0.170 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 299 | 0.170 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 17 | 0.160 |
Why?
|
| Humans | 24 | 2025 | 98076 | 0.160 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 396 | 0.150 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2017 | 266 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 134 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 269 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 7389 | 0.140 |
Why?
|
| Cutaneous Fistula | 1 | 2017 | 10 | 0.130 |
Why?
|
| Vascular Fistula | 1 | 2017 | 12 | 0.130 |
Why?
|
| Hemostasis, Surgical | 1 | 2017 | 23 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 62 | 0.120 |
Why?
|
| Hemostatics | 1 | 2017 | 64 | 0.120 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 55 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 2 | 2008 | 126 | 0.120 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2016 | 1 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 103 | 0.120 |
Why?
|
| Angiography | 2 | 2014 | 194 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 811 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 1782 | 0.120 |
Why?
|
| Radiography, Interventional | 2 | 2013 | 157 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 92 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2016 | 91 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2017 | 198 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 118 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2013 | 138 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2025 | 4823 | 0.100 |
Why?
|
| Ligation | 1 | 2014 | 55 | 0.100 |
Why?
|
| Cardiac Catheters | 1 | 2013 | 20 | 0.100 |
Why?
|
| Surgical Instruments | 1 | 2014 | 69 | 0.100 |
Why?
|
| Aortography | 1 | 2013 | 60 | 0.100 |
Why?
|
| Time Factors | 4 | 2025 | 5567 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2013 | 116 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2016 | 381 | 0.090 |
Why?
|
| Punctures | 1 | 2011 | 29 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 461 | 0.080 |
Why?
|
| Retreatment | 1 | 2010 | 107 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 4025 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 2585 | 0.080 |
Why?
|
| Middle Aged | 5 | 2024 | 29427 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2010 | 233 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2024 | 370 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 6232 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 15 | 0.070 |
Why?
|
| Platelet Aggregation | 1 | 2008 | 40 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 25 | 0.070 |
Why?
|
| Metals | 1 | 2008 | 104 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 31 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 1193 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2666 | 0.060 |
Why?
|
| Hospitalization | 2 | 2023 | 991 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2010 | 1527 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2020 | 10972 | 0.060 |
Why?
|
| Female | 7 | 2025 | 51535 | 0.050 |
Why?
|
| Mitral Valve Stenosis | 1 | 2024 | 27 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 211 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 984 | 0.050 |
Why?
|
| Pharmacogenomic Variants | 1 | 2022 | 46 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1254 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 169 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2022 | 119 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 299 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 977 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2024 | 747 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 4116 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 1888 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1123 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 76 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 75 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 108 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 305 | 0.030 |
Why?
|
| Stroke | 1 | 2024 | 1154 | 0.030 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 339 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 727 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 726 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2013 | 41 | 0.020 |
Why?
|
| Arterial Pressure | 1 | 2013 | 44 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 425 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 1895 | 0.020 |
Why?
|
| Aorta | 1 | 2013 | 275 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 264 | 0.020 |
Why?
|
| United States | 1 | 2024 | 8196 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 534 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 527 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 140 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 540 | 0.020 |
Why?
|
| Contrast Media | 1 | 2013 | 1011 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2011 | 268 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 60 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 155 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 1491 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 29538 | 0.010 |
Why?
|